• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Criminal behavior more associated with frontotemporal dementia than Alzheimer disease

byAshley AaroeandJames Jiang
January 7, 2015
in Chronic Disease, Neurology, Psychiatry
Reading Time: 3 mins read
Criminal behavior more associated with frontotemporal dementia than Alzheimer disease
Share on FacebookShare on TwitterShare on LinkedIn

1. There was a greater association between criminality and behavioral variant frontotemporal dementia (bvFTD) than there was between criminality and Alzheimer disease (AD).

2. Patients with bvFTD were significantly more likely to have criminal behavior as a first presentation of disease. There was also a trend in patients with bvFTD to commit crimes characterized by violence more so than patients with AD.

Evidence Rating Level: 4 (Below Average)

Study Rundown: Neurodegenerative diseases, which encompass Alzheimer disease, Huntington disease, and frontotemporal dementia among others, result in damage of structures responsible for higher intellectual functions. These functions, such as impulse control, logical reasoning, self-awareness and emotional processing, are fundamental to the success of an individual in navigating social mores and, beyond that, laws. As a result, patients without a history of prior arrests may suddenly commit criminal behavior. This study sought to investigate the incidence of criminal behavior in patients with dementing disorders.

Criminal behavior was ultimately detected in 7.7% of patients with AD, 37.4% with bvFTD, 27.0% with semantic variant of primary progressive aphasia, and 20% of those with Huntington disease. A strength of this study was the attention paid to correlating clinical diagnoses with pathologic results, which decreases confounding. Further, the authors made an effort to hypothesize at what point in the disease criminal behaviors manifested. A weakness was that actual criminal records were not available for study. The study suggests that subtleties in the type of criminal behavior exhibited varies between different dementing disorders, and may represent predilection of the diseases to affect certain parts of the brain. However this particular study was underpowered to confirm these suggestions, and further research is warranted.

Click to read the study, published today in JAMA Neurology

RELATED REPORTS

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

2 Minute Medicine Rewind October 12, 2026

Relevant Reading: Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review

In-Depth [cross-sectional study]: This cross sectional study reviewed records including 13,477 patient notes representing 2,397 patients seen at the UCSF Memory and Aging Center between 1999 and 2012 for keywords representing criminal behavior, decided on by two authors of the paper. A total of 204 patients were identified as having exhibited criminal behaviors, defined as acts violating the law or deviating from social decorum that could lead to legal ramifications. Of these, 31 individuals were deceased and subsequent pathology postmortem analysis was performed with 93% concordance between clinical and pathologic diagnoses.

Criminal behavior was ultimately detected in 7.7% of patients with AD, 37.4% with bvFTD, 27.0% with semantic variant of primary progressive aphasia (svPPA), and 20% of those with Huntington disease. Patients with bvFTD were more likely to have criminal behavior as a first presentation of disease with 14% of patients, compared to 7.8% of patients with svPPA and 2% of patients with AD (P<0.001). In the bvFTD group, 6.4% of the patients exhibited some form of criminality specifically characterized by violence, compared to 3.4% of patients with svPPA and 2.0% of patients with AD (P=0.30 and P=0.003, respectively).

More from this author: “No Evidence of Disease Activity” may be useful goal in multiple sclerosis, Hyperbaric oxygen does not significantly improve post-concussion symptoms, Increased orexin levels linked with poor sleep quality in Alzheimer Disease, Antibiotic prescription patterns in China may contribute to resistance, Glatiramer acetate (Copaxone) therapy may alter B cell function in multiple sclerosis

Image: CC/Sam Howzit

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Alzheimer’s diseasedementia
Previous Post

HPV vaccine not associated with Multiple Sclerosis

Next Post

Whole grain consumption associated with decreased all-cause, cardiovascular mortality

RelatedReports

A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind October 12, 2026

October 17, 2026
An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

Dementia diagnosis underreporting is common and associated with reduced care engagement

August 29, 2026
Next Post
Whole grain consumption associated with decreased all-cause, cardiovascular mortality

Whole grain consumption associated with decreased all-cause, cardiovascular mortality

Standardized measures effectively tracked psoriasis and acne outcomes

Standardized measures effectively tracked psoriasis and acne outcomes

Classics Series, Landmark Trials in Medicine

The AMPLIFY trial: Apixaban for treatment of venous thromboembolism [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
  • Children with autism spectrum disorder may have reduced fecal microbial diversity
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.